Conexeu Sciences (CNXU) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.06, -22.53% vs the prior close of $3.95.
- Volume 663.58K shares, 2.5x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CNXU slides 22.5% to $3.06, a 3-month low on 2.5x normal volume. Closed at $3.06, -22.53% vs the prior close of $3.95. Day range $3.05–$4.00, opened at $3.96.
CNXU daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CNXU slides 22.5% to $3.06, a 3-month low on 2.5x normal volume
- Closed at $3.06, -22.53% vs the prior close of $3.95. Day range $3.05–$4.00, opened at $3.96.
- Volume was 663.58K shares, 2.5x its 50-day average of 265.81K — unusually heavy trading.
- Price is -44.5% vs its 50-day average ($5.51).
- 52-week range $3.05–$18.79; today's close sits at 0% of that range, 83.7% below the 52-week high.
Oct 15, 2026 — CNXU jumps 8.2% to $3.95 on 2.3x normal volume
- Closed at $3.95, +8.22% vs the prior close of $3.65. Day range $3.40–$4.05, opened at $3.66.
- Volume was 600.30K shares, 2.3x its 50-day average of 257.15K — unusually heavy trading.
- Price is -29.7% vs its 50-day average ($5.62).
- 52-week range $3.05–$18.79; today's close sits at 6% of that range, 79.0% below the 52-week high.
Oct 14, 2026 — CNXU jumps 10.3% to $3.65 on 4.8x normal volume
- Closed at $3.65, +10.27% vs the prior close of $3.31. Day range $3.42–$4.36, opened at $3.44.
- Volume was 1.15M shares, 4.8x its 50-day average of 237.32K — unusually heavy trading.
- Price is -36.2% vs its 50-day average ($5.72).
- 52-week range $3.05–$18.79; today's close sits at 4% of that range, 80.6% below the 52-week high.
Oct 13, 2026 — CNXU slides 12.2% to $3.31
- Closed at $3.31, -12.20% vs the prior close of $3.77. Day range $3.30–$3.97, opened at $3.78.
- Volume was 284.30K shares, 1.2x its 50-day average of 234.28K.
- Price is -43.2% vs its 50-day average ($5.83).
- 52-week range $3.05–$18.79; today's close sits at 2% of that range, 82.4% below the 52-week high.
Oct 12, 2026 — CNXU slides 3.1% to $3.77
- Closed at $3.77, -3.08% vs the prior close of $3.89. Day range $3.65–$4.10, opened at $4.10.
- Volume was 362.80K shares, 1.6x its 50-day average of 230.34K.
- Price is -36.3% vs its 50-day average ($5.92).
- 52-week range $3.05–$18.79; today's close sits at 5% of that range, 79.9% below the 52-week high.
Oct 9, 2026 — CNXU jumps 12.8% to $3.89 on 1.9x normal volume
- Closed at $3.89, +12.75% vs the prior close of $3.45. Day range $3.47–$4.22, opened at $3.50.
- Volume was 427.70K shares, 1.9x its 50-day average of 225.00K — unusually heavy trading.
- Price is -35.3% vs its 50-day average ($6.01).
- 52-week range $3.05–$18.79; today's close sits at 5% of that range, 79.3% below the 52-week high.
Oct 8, 2026 — CNXU slides 5.2% to $3.45
- Closed at $3.45, -5.22% vs the prior close of $3.64. Day range $3.30–$3.68, opened at $3.64.
- Volume was 243.50K shares, 1.1x its 50-day average of 222.58K.
- Price is -43.5% vs its 50-day average ($6.11).
- 52-week range $3.05–$18.79; today's close sits at 3% of that range, 81.6% below the 52-week high.
Oct 7, 2026 — CNXU dips 0.5% to $3.64
- Closed at $3.64, -0.55% vs the prior close of $3.66. Day range $3.47–$3.75, opened at $3.68.
- Volume was 239.00K shares, 1.1x its 50-day average of 219.37K.
- Price is -41.3% vs its 50-day average ($6.20).
- 52-week range $3.05–$18.79; today's close sits at 4% of that range, 80.6% below the 52-week high.
Oct 6, 2026 — CNXU jumps 17.3% to $3.66
- Closed at $3.66, +17.31% vs the prior close of $3.12. Day range $3.15–$3.74, opened at $3.33.
- Volume was 328.30K shares, 1.5x its 50-day average of 215.62K.
- Price is -41.7% vs its 50-day average ($6.28).
- 52-week range $3.05–$18.79; today's close sits at 4% of that range, 80.5% below the 52-week high.
Oct 5, 2026 — CNXU rises 0.6% to $3.12
- Closed at $3.12, +0.65% vs the prior close of $3.10. Day range $3.05–$3.24, opened at $3.07.
- Volume was 171.20K shares, 0.8x its 50-day average of 213.42K.
- Price is -51.0% vs its 50-day average ($6.36).
- 52-week range $3.05–$18.79; today's close sits at 0% of that range, 83.4% below the 52-week high.
Oct 2, 2026 — CNXU slides 6.6% to $3.10, a 3-month low, 11 down days in a row
- Closed at $3.10, -6.63% vs the prior close of $3.32. Day range $3.10–$3.41, opened at $3.33.
- Volume was 114.30K shares, 0.5x its 50-day average of 212.58K — lighter than usual.
- Price is -52.1% vs its 50-day average ($6.47).
- 52-week range $3.10–$18.79; today's close sits at 0% of that range, 83.5% below the 52-week high.
- That makes 11 straight losses.
CNXU latest news & SEC filings
Every SEC filing by or about CNXU in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bogart David Robert converted options/RSUs into 750,000 shares at $0.00 (≈$750) on Sep 25, 2026; now holds 1,812,500
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 15, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 15, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jul 31, 2026:
- Net income: -$7.73M (prior year -$1.30M) (loss widened vs Jul 31, 2025)
- Diluted EPS: -$0.29 (prior year -$0.09) (loss widened vs Jul 31, 2025)
Sep 10, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.02 — Sold unregistered shares.
Sep 9, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 4, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 18, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade CNXU
- How much it moves: over the last 20 sessions the average daily move was 6.92% (largest 22.5%). That is a volatile stock.
- Liquidity: about 305.05K shares (≈$933.45K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.06 vs a range of $3.05–$18.79 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 12 open-market buys, 0 sales; latest: Lynn Sebastian Purcell bought 202,500 shares on Jun 18, 2026.
- Latest filings: 10-Q Sep 14, 2026; 8-K Sep 10, 2026; 8-K Jul 7, 2026.
- Listing: Nasdaq · industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies.
CNXU market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.96 | 4.00 | 3.05 | 3.06 | 663.58K |
| Oct 15, 2026 | 3.66 | 4.05 | 3.40 | 3.95 | 600.30K |
| Oct 14, 2026 | 3.44 | 4.36 | 3.42 | 3.65 | 1.15M |
| Oct 13, 2026 | 3.78 | 3.97 | 3.30 | 3.31 | 284.30K |
| Oct 12, 2026 | 4.10 | 4.10 | 3.65 | 3.77 | 362.80K |
| Oct 9, 2026 | 3.50 | 4.22 | 3.47 | 3.89 | 427.70K |
| Oct 8, 2026 | 3.64 | 3.68 | 3.30 | 3.45 | 243.50K |
| Oct 7, 2026 | 3.68 | 3.75 | 3.47 | 3.64 | 239.00K |
| Oct 6, 2026 | 3.33 | 3.74 | 3.15 | 3.66 | 328.30K |
| Oct 5, 2026 | 3.07 | 3.24 | 3.05 | 3.12 | 171.20K |
| Oct 2, 2026 | 3.33 | 3.41 | 3.10 | 3.10 | 114.30K |
| Oct 1, 2026 | 3.51 | 3.60 | 3.32 | 3.32 | 95.80K |
| Sep 30, 2026 | 3.68 | 3.74 | 3.45 | 3.57 | 194.90K |
| Sep 29, 2026 | 3.74 | 3.84 | 3.60 | 3.71 | 241.50K |
| Sep 28, 2026 | 3.89 | 3.90 | 3.69 | 3.77 | 179.60K |
| Sep 25, 2026 | 4.03 | 4.11 | 3.82 | 3.89 | 111.20K |
| Sep 24, 2026 | 4.09 | 4.22 | 3.82 | 3.96 | 163.60K |
| Sep 23, 2026 | 4.37 | 4.50 | 3.86 | 4.21 | 235.10K |
| Sep 22, 2026 | 4.81 | 4.87 | 4.40 | 4.40 | 158.20K |
| Sep 21, 2026 | 5.02 | 5.02 | 4.62 | 4.75 | 138.30K |
About Conexeu Sciences
Conexeu Sciences (CNXU) is listed on the Nasdaq and classified by the SEC under “Orthopedic, Prosthetic & Surgical Appliances & Supplies”. Its business address is in RENO, NV. State of incorporation: NV. Fiscal year ends October 31. SEC CIK 2066836.
CNXU board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ana Lucia Bastiani-Posner | Director | Jun 23, 2026 |
| David Robert Bogart | Chief Commercial Officer | Sep 28, 2026 |
| April Lynn Burke | Director | Jun 24, 2026 |
| Andrew Costa | Director | Jun 29, 2026 |
| Aaron Solomon Farberg | Director | May 11, 2026 |
| Miles David Harrison | President and CEO | May 11, 2026 |
| Zbigniew Paul Lorenc | Director | May 15, 2026 |
| Lynn Sebastian Purcell | Director | Sep 9, 2026 |
| Jeffrey Nathan Sharpe | Director | Sep 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| David Robert Bogart | Chief Commercial Officer | Sep 28, 2026 |
| Claudia Itze Chavez-Munoz | Chief Science Officer | May 11, 2026 |
| Miles David Harrison | President and CEO | May 11, 2026 |
| Stephen Douglas Inouye | CFO, Secretary, and Treasurer | May 11, 2026 |
| Brian Keith Pilcher | Chief Medical Officer | May 11, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 18, 2026 | Lynn Sebastian Purcell | Buy | 202,500 | $0.80 |
| Jun 18, 2026 | Lynn Sebastian Purcell | Buy | 202,500 | $0.80 |
| Jun 18, 2026 | Lynn Sebastian Purcell | Buy | 202,500 | $0.80 |
| Jun 18, 2026 | Lynn Sebastian Purcell | Buy | 202,500 | $0.80 |
| May 12, 2026 | Lynn Sebastian Purcell | Buy | 422,500 | $0.80 |
| May 12, 2026 | Lynn Sebastian Purcell | Buy | 422,500 | $0.80 |
| May 12, 2026 | Lynn Sebastian Purcell | Buy | 422,500 | $0.80 |
| May 12, 2026 | Lynn Sebastian Purcell | Buy | 422,500 | $0.80 |
| May 12, 2026 | Capital Ventures Llc Onepointtwo | Buy | 422,500 | $0.80 |
| May 12, 2026 | Capital Ventures Llc Onepointtwo | Buy | 422,500 | $0.80 |
| May 12, 2026 | Capital Ventures Llc Onepointtwo | Buy | 422,500 | $0.80 |
| May 12, 2026 | Capital Ventures Llc Onepointtwo | Buy | 422,500 | $0.80 |
CNXU financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $7.16M, total liabilities $1.31M, cash $1.97M (as of Jul 31, 2026).
CNXU earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Intuitive Surgical (ISRG)Edwards Lifesciences (EW)Zimmer Biomet (ZBH)Align Technology (ALGN)Steris (STE)MSA Safety (MSA)Smith & Nephew (SNN)Enovis (ENOV)Establishment Labs (ESTA)Cadre (CDRE)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CNXU
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.